<DOC>
	<DOCNO>NCT00442793</DOCNO>
	<brief_summary>This 2 arm study compare effect hemoglobin response Mircera epoetin beta , patient chronic renal anemia dialysis . Eligible patient randomize receive either Mircera ( 0.4 micrograms/kg i.v . every 2 week ) epoetin beta ( 3 time weekly , accord approve labelling ) . The anticipated time study treatment 3-12 month , target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study Comparing Mircera Epoetin Beta Treatment Anemia Dialysis Patients With Chronic Kidney Disease .</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>adult patient , &gt; =18 year age ; chronic renal anemia require dialysis ; maintenance hemodialysis peritoneal dialysis &gt; =2 week screen ; adequate iron status . previous epoetin treatment within 8 week prior screen ; fail renal graft place ; bleed episode necessitate transfusion within 8 week prior screen ; poorly control hypertension ; previous treatment Mircera .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>